Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 41,196 shares at $8.14 ($335K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
Seasonal sale ($335k) by Executive VP, European Commercial — this insider has traded TEVA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.14 | 20,598 | $168K | 50.0% |
| 2 | $8.14 | 20,598 | $168K | 50.0% |
| Total | $8.14 avg | 41,196 | $335K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |